Clinical Trial Update: Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity reports completed phases 2 and 3 with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Weight Loss Disorders

Snippet

Sponsor: Northwestern University | Conditions: Weight Loss | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-05